医学
奥马佐单抗
特应性皮炎
免疫球蛋白E
哮喘
皮肤病科
生活质量(医疗保健)
免疫学
抗体
护理部
出处
期刊:JAMA
[American Medical Association]
日期:2020-02-25
卷期号:323 (8): 701-701
标识
DOI:10.1001/jama.2020.1007
摘要
Omalizumab, an anti-IgE medication approved to treat asthma and hives, significantly reduced children’s atopic dermatitis severity and improved their quality of life, according to a trial in JAMA Pediatrics.
科研通智能强力驱动
Strongly Powered by AbleSci AI